3Yu VY. Extrauterine growth restriction in pretrem infants:importance of optimizing nutrition in neonatal intensive care units[J].Croatian Medical Journal,2005,(05):737-743.
4Pieltain C,Habibi F,Rigo J. Early nutrition,postnatal gowth retardation and outcome of VLBW infans[J].Archives de Pediatrie,2007,(Suppl 1):S11-S15.
5Murdock N,Crighton A,Nelsonl M. Low-birth-weight infants and toal parenteral nutrition immediately after birth.Ⅱ.Randomized study of biochemical tolerance of intravenous glucose,amino acids and lipid[J].Archives of Disease in Childhood:Fetal and Neonatal Edition,1995,(01):F8-12.
6Denne SC. Regulation of proteolysis and optimal protein accretion in extremely premature newborns[J].American Journal of Clinical Nutrition,2007,(02):62IS-624S.
7Vlaardingerbroek H,Van den AKKER CH. lnitial nutritional man-agement of the preterm infant[J].Early Human and Development,2009,(11):691-695.
8Galligan JJ,Vanner S. Basic and clinical pharmacology of new motility promoting agents[J].Neurogastroenterology and Motility,2005,(05):643.doi:10.1111/j.1365-2982.2005.00675.x.
9Chen CY,Tao PN,Chen HL. Ursodeoxycholic acid(UDCA)therapy in very low-birth-rweight infants with parenteral nutrition-associated cholestasis[J].Journal of Pediatrics,2004,(03):317-321.
10Al-Hathlol K,Al-Madani A,Al-Saif S. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-asspciated cholestasis in surgical very low birth weight infants[J].Singapore Medical Journal,2006,(02):147-151.
